These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3733302)
1. Immunobiological activities of nontoxic lipid A: enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects. Masihi KN; Lange W; Brehmer W; Ribi E Int J Immunopharmacol; 1986; 8(3):339-45. PubMed ID: 3733302 [TBL] [Abstract][Full Text] [Related]
2. Correlation between augmented resistance to influenza virus infection and histological changes in lung of mice treated with trehalose-6,6'-dimycolate. Azuma M; Sazaki K; Nishikawa Y; Takahashi T; Shimoda A; Suzutani T; Yoshida I; Sakuma T; Nakaya K J Biol Response Mod; 1988 Oct; 7(5):473-82. PubMed ID: 2460592 [TBL] [Abstract][Full Text] [Related]
3. Stimulation of chemiluminescence and resistance against aerogenic influenza virus infection by synthetic muramyl dipeptide combined with trehalose dimycolate. Masihi KN; Brehmer W; Azuma I; Lange W; Müller S Infect Immun; 1984 Jan; 43(1):233-7. PubMed ID: 6317568 [TBL] [Abstract][Full Text] [Related]
4. Protective effect of muramyl dipeptide analogs in combination with trehalose dimycolate against aerogenic influenza virus and Mycobacterium tuberculosis infections in mice. Masihi KN; Brehmer W; Lange W; Ribi E; Schwartzman S J Biol Response Mod; 1984 Dec; 3(6):663-71. PubMed ID: 6439830 [TBL] [Abstract][Full Text] [Related]
5. Trehalose dimycolate enhances resistance to infection in neutropenic animals. Madonna GS; Ledney GD; Elliott TB; Brook I; Ulrich JT; Myers KR; Patchen ML; Walker RI Infect Immun; 1989 Aug; 57(8):2495-501. PubMed ID: 2663726 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of augmented resistance of cyclosporin A-treated mice to influenza virus infection by trehalose-6,6'-dimycolate. Sazaki K; Yoshida I; Azuma M Microbiol Immunol; 1992; 36(10):1061-75. PubMed ID: 1282653 [TBL] [Abstract][Full Text] [Related]
7. Effects of mycobacterial fractions and muramyl dipeptide on the resistance of mice to aerogenic influenza virus infection. Masihi KN; Brehmer W; Lange W; Ribi E Int J Immunopharmacol; 1983; 5(5):403-10. PubMed ID: 6654538 [TBL] [Abstract][Full Text] [Related]
8. Monophosphoryl lipid A-induced immune enhancement of Brucella abortus salt-extractable protein and lipopolysaccharide vaccines in BALB/c mice. Tabatabai LB; Pugh GW; Stevens MG; Phillips M; McDonald TJ Am J Vet Res; 1992 Oct; 53(10):1900-7. PubMed ID: 1456539 [TBL] [Abstract][Full Text] [Related]
9. Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route. Ravindran R; Maji M; Ali N Mol Pharm; 2012 Jan; 9(1):59-70. PubMed ID: 22133194 [TBL] [Abstract][Full Text] [Related]
10. Effects of muramyl dipeptide and trehalose dimycolate on resistance of mice to Toxoplasma gondii and Acanthamoeba culbertsoni infections. Masihi KN; Bhaduri CR; Werner H; Janitschke K; Lange W Int Arch Allergy Appl Immunol; 1986; 81(2):112-7. PubMed ID: 3759255 [TBL] [Abstract][Full Text] [Related]
11. Modulation of natural killer cytotoxicity by muramyl dipeptide and trehalose dimycolate incorporated in squalane droplets. Masihi KN; Lange W; Rohde-Schulz B Cancer Immunol Immunother; 1987; 24(1):19-24. PubMed ID: 3815418 [TBL] [Abstract][Full Text] [Related]
12. Role of interferon in the augmented resistance of trehalose-6,6'-dimycolate-treated mice to influenza virus infection. Azuma M; Suzutani T; Sazaki K; Yoshida I; Sakuma T; Yoshida T J Gen Virol; 1987 Mar; 68 ( Pt 3)():835-43. PubMed ID: 3493326 [TBL] [Abstract][Full Text] [Related]
13. Insufficient resistance of trehalose-6,6-dimycolate-treated T-cell receptor delta gene mutant (TCR delta-/-) mice against influenza virus infection. Hoq MM; Suzutani T; Nakaya K; Yoshida I; Ogasawara M; Takeda Y; Shibaki T; Itohara S; Yamamoto H; Azuma M Microbiol Immunol; 1999; 43(5):491-3. PubMed ID: 10449256 [TBL] [Abstract][Full Text] [Related]
14. Role of gamma delta TCR+ lymphocytes in the augmented resistance of trehalose 6,6'-dimycolate-treated mice to influenza virus infection. Hoq MM; Suzutani T; Toyoda T; Horiike G; Yoshida I; Azuma M J Gen Virol; 1997 Jul; 78 ( Pt 7)():1597-603. PubMed ID: 9225035 [TBL] [Abstract][Full Text] [Related]
15. Enhancers of nonspecific immunity induce nitric oxide synthase: induction does not correlate with toxicity or adjuvancy. Palacios M; Knowles RG; Moncada S Eur J Immunol; 1992 Sep; 22(9):2303-7. PubMed ID: 1381314 [TBL] [Abstract][Full Text] [Related]
16. Trehalose dimycolate from various mycobacterial species induces differing anti-infectious activities in combination with muramyl dipeptide. Masihi KN; Brehmer W; Lange W; Werner H; Ribi E Infect Immun; 1985 Dec; 50(3):938-40. PubMed ID: 4066040 [TBL] [Abstract][Full Text] [Related]
18. Effect of immunomodulator adamantylamide dipeptide on antibody response to influenza subunit vaccines and protection against aerosol influenza infection. Masihi KN; Lange W; Schwenke S; Gast G; Huchshorn P; Palache A; Masek K Vaccine; 1990 Apr; 8(2):159-63. PubMed ID: 2336875 [TBL] [Abstract][Full Text] [Related]
19. Biomedical applications of chromatographic fraction containing trehalose dimycolate in squalane emulsion. Masihi KN; Lange W; Ozel M J Chromatogr; 1988 May; 440():473-8. PubMed ID: 3042798 [TBL] [Abstract][Full Text] [Related]
20. Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine. Ko EJ; Lee YT; Kim KH; Lee Y; Jung YJ; Kim MC; Lee YN; Kang T; Kang SM J Immunol; 2017 Jan; 198(1):279-291. PubMed ID: 27881702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]